KD Logo

An Analysis of Sutro Biopharma Inc (STRO)’s Potential Price Growth

In a filing, Sutro Biopharma Inc revealed its CHIEF PORT. STRAT & ALNCE OFCR Vasquez Nicki unloaded Company’s shares for reported $60925.0 on Jan 29 ’24. In the deal valued at $5.00 per share,12,185 shares were sold. As a result of this transaction, Vasquez Nicki now holds 12,803 shares worth roughly $43402.17.

Then, Shtylla Brunilda sold 15,428 shares, generating $72,595 in total proceeds. Upon selling the shares at $4.71, the Chief Business Officer now owns 0 shares.

Before that, Shtylla Brunilda sold 11,613 shares. Sutro Biopharma Inc shares valued at $53,282 were divested by the Chief Business Officer at a price of $4.59 per share. As a result of the transaction, Shtylla Brunilda now holds 12,928 shares, worth roughly $43825.92.

Deutsche Bank initiated its Sutro Biopharma Inc [STRO] rating to a Buy in a research note published on November 09, 2023; the price target was $12. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who began to cover the stock in early October with a ‘”an Outperform”‘ rating. Wells Fargo also remained covering STRO and has decreased its forecast on March 21, 2023 with a “an Equal weight” recommendation from previously “an Overweight” rating.

Price Performance Review of STRO

On Tuesday, Sutro Biopharma Inc [NASDAQ:STRO] saw its stock fall -3.55% to $3.39. Over the last five days, the stock has lost -8.74%. Sutro Biopharma Inc shares have fallen nearly -20.86% since the year began. Nevertheless, the stocks have fallen -20.31% over the past one year. While a 52-week high of $6.13 was reached on 03/28/24, a 52-week low of $2.01 was recorded on 03/20/24. SMA at 50 days reached $4.31, while 200 days put it at $3.96. A total of 0.51 million shares were traded, compared to the trading of 0.55 million shares in the previous session.

Levels Of Support And Resistance For STRO Stock

The 24-hour chart illustrates a support level at 3.33, which if violated will result in even more drops to 3.25. On the upside, there is a resistance level at 3.49. A further resistance level may holdings at 3.58. The Relative Strength Index (RSI) on the 14-day chart is 36.30, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.31, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.99%. Stochastics %K at 10.51% indicates the stock is a buying.

The most recent change occurred on June 18, 2021 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $35 price target.

Most Popular

[the_ad id="945"]